GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 46.5

(-1.06%)

Net Income Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual net income in 2023 was 124.62 Million TWD , up 33.35% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly net income in 2024 Q2 was -6.03 Million TWD , up 27.44% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported an annual net income of 93.45 Million TWD in 2022, up 62.77% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported an annual net income of 57.41 Million TWD in 2021, up 1167.67% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly net income of -6.03 Million TWD for 2024 Q2, up 27.44% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported a quarterly net income of 46.8 Million TWD for 2023 Q2, up 53.63% from previous quarter.

Annual Net Income Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Historical Annual Net Income of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 124.62 Million TWD 33.35%
2022 93.45 Million TWD 62.77%
2021 57.41 Million TWD 1167.67%
2020 4.52 Million TWD 116.44%
2019 -27.55 Million TWD 0.0%

Peer Net Income Comparison of GeneFerm Biotechnology Co., Ltd.

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD -27.932%
Easywell Biomedicals, Inc. -144.81 Million TWD 186.054%
TTY Biopharm Company Limited 1.12 Billion TWD 88.957%
Synmosa Biopharma Corporation 594.83 Million TWD 79.049%
Orient EuroPharma Co., Ltd. 143.94 Million TWD 13.423%
Center Laboratories, Inc. -995.42 Million TWD 112.519%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD -602.803%
Orient Pharma Co., Ltd. 22.28 Million TWD -459.139%
InnoPharmax Inc. -70.83 Million TWD 275.941%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD -56.363%
Excelsior Biopharma Inc. -91.01 Million TWD 236.93%
DV Biomed Co., Ltd. 162.91 Million TWD 23.503%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 112.026%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 82.855%
UniPharma Co., Ltd. -21.81 Million TWD 671.315%
Anxo Pharmaceutical Co., Ltd. 21.86 Million TWD -470.061%
Alar Pharmaceuticals Inc. 382.61 Million TWD 67.429%
Winston Medical Supply Co., Ltd. 158.75 Million TWD 21.501%
Mercury Biopharmaceutical Corporation -43.81 Million TWD 384.419%
Bioray Biotech Co., Ltd -11.55 Million TWD 1178.13%
TSH Biopharm Corporation Limited 61.98 Million TWD -101.037%